We are deeply saddened to hear of the passing of Her Majesty The Queen. She has been a constant in our lives and the only monarch we have known. We would like to thank her for her dedicated service to her country and the Commonwealth for 70 years and send our heartfelt condolences to all
Category: Interview
To celebrate International Women’s Day 2022 – Helen Spencer (Consultant BDM and Marketer) asked Scientific Update Ltd joint owners and Directors Dr Claire Francis and Hannah May – a few questions about their career journey. Q: Do you think it is important to celebrate International Women’s Day? A: CF: Yes, for me it is an
Interview with Technical Director Dr Will Watson from Scientific Update on CKHTV Chemicals Knowledge Hub TV
We recently had the pleasure of speaking with Iwona Kaluzna, Sales and Marketing Director at InnoSyn to learn about the key challenges and most exciting research areas in biocatalysis. Read the blog article by Laura Elizabeth Lansdowne, Senior Science Writer & Editor, Technology Networks: Link to article: Advances in Industrial Biocatalysis Iwona is presenting at
Dr John Studley, Science Director at Scientific Update and Dr Rachel Grainger from Astex Pharmaceuticals got together ahead of our forthcoming Organic Process R&D Conference in Lisbon, Portugal on 23-25 September. Q: Dr John Studley (JS) Can you give us an overview of Fragment Based Drug Discovery (FBDD) and how you see the technique evolving over the next decade? A:
Dr John Studley, Science Director at Scientific Update and Dr William Goundry from Astra Zeneca got together ahead of our forthcoming Organic Process R&D Conference in Lisbon, Portugal on 23-25 September. Q: Dr John Studley (JS) We are looking forward to your presentation ‘The Good, the Bad and the Ugly! Successes and Failures from the
Dr John Studley, Scientific Director at Scientific Update recently spoke to Dr Boris Gorin, Eurofins Alphora, Toronto, Canada ahead of his presentation at the 2019 ‘Organic Process Research & Development’ Conference in Toronto, Canada. Boris will talk about “Eribulin Mesylate, a Journey from Synthetic Route Discovery to Scale-Up Manufacture”. John Studley (JS): Can you tell us a bit
